Based on the CARASENT ASA NK 1332 stock forecast from 0 analysts, the average analyst target price for CARASENT ASA NK 1332 is not available over the next 12 months. CARASENT ASA NK 1332’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of CARASENT ASA NK 1332 is Slightly Bearish, which is based on 1 positive signals and 2 negative signals. At the last closing, CARASENT ASA NK 1332’s stock price was EUR 1.74. CARASENT ASA NK 1332’s stock price has changed by +0.00% over the past week, +0.00% over the past month and +80.87% over the last year.
No recent analyst target price found for CARASENT ASA NK 1332
No recent average analyst rating found for CARASENT ASA NK 1332
Company Overview CARASENT ASA NK 1332
Carasent ASA provides cloud based electronic health record solutions to the health care industry in Sweden, Norway, and internationally. The company offers Webdoc, a cloud-based EHR system; Metodika EPM, a solution designed for mid-to-large-sized organizations; Medrave M4 to give healthcare staff and managers an overview and clear picture of the patient group being treated; Health Profile Institute AB (HPI), an occupational care platform; Ad Curis, a record system with digital services tailored for the specialist healthcare service with clients in rehabilitation, interdisciplinary specialized drug treatment, and mental health care, as well as businesses in care and prevention; and Ad Opus, a journal system for follow-up of participants in measures. It also provides platform services, such as Vårdrummet, Confrere, Ad Voca, electronic letters, SMS services, portal to medical services, and consulting and other services. The company was formerly known as Apptix ASA and changed its name to Carasent ASA in May 2019. Carasent ASA was founded in 1997 and is based in Oslo, Norway. Read Less
Carasent ASA provides cloud based electronic health record solutions to the health care industry in Sweden, Norway, and internationally. The company offers Webdoc, a cloud-based EHR system; Metodika EPM, a solution designed for mid-to-large-sized organizations; Medrave M4 to give...Read More
Frequently Asked Questions About CARASENT ASA NK 1332 (C34:F) Stock
Stock Target Advisor's fundamental analysis for CARASENT ASA NK 1332's stock is Slightly Bearish.
Unfortunately we do not have enough data on C34:F's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on C34:F's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on C34:F's stock to indicate if its overvalued.
The last closing price of C34:F's stock was EUR 1.74.
The most recent market capitalization for C34:F is EUR 0.13B.
Unfortunately we do not have enough analyst data on C34:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains CARASENT ASA NK 1332's stock.
As per our most recent records CARASENT ASA NK 1332 has 169 Employees.
CARASENT ASA NK 1332's registered address is Oevre Slottsgate 2B, Oslo, Norway, 0157.
You can get more information about it from CARASENT ASA NK 1332's website at https://carasent.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
What not to like
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About CARASENT ASA NK 1332 (C34:F) Stock
Stock Target Advisor's fundamental analysis for CARASENT ASA NK 1332's stock is Slightly Bearish.
Unfortunately we do not have enough data on C34:F's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on C34:F's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on C34:F's stock to indicate if its overvalued.
The last closing price of C34:F's stock was EUR 1.74.
The most recent market capitalization for C34:F is EUR 0.13B.
Unfortunately we do not have enough analyst data on C34:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains CARASENT ASA NK 1332's stock.
As per our most recent records CARASENT ASA NK 1332 has 169 Employees.
CARASENT ASA NK 1332's registered address is Oevre Slottsgate 2B, Oslo, Norway, 0157.
You can get more information about it from CARASENT ASA NK 1332's website at https://carasent.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for C34:F !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
